Literature DB >> 4044586

Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins.

J M Lambert, P D Senter, A Yau-Young, W A Blättler, V S Goldmacher.   

Abstract

Seven different monoclonal antibodies of the IgG class that are reactive with four different antigens on human lymphoid cells were utilized to form immunotoxins with the ribosome-inactivating proteins gelonin and the three known pokeweed antiviral proteins. Thirteen different immunotoxin combinations were prepared. The ribosome-inactivating proteins were modified with 2-iminothiolane. The sulfhydryl groups so introduced were reacted with maleimido groups or with dithiopyridyl groups that had been introduced into the antibodies. The toxin-antibody conjugates so formed were purified by affinity chromatography on protein A-Sepharose CL-4B, ion exchange chromatography, and by gel filtration and were characterized by polyacrylamide-dodecyl sulfate gel electrophoresis. The purified immunotoxins were free of nonconjugated monomeric proteins and aggregates of very high molecular weight. All the immunotoxins showed the specific binding of the component antibody as measured by indirect immunofluorescence binding assays. The activities of the ribosome-inactivating proteins were unaffected by conjugation where the cross-link to the antibody contained a disulfide bond and when assayed after reductive cleavage of the linker. Disulfide-linked immunotoxins with six of the antibodies were highly cytotoxic for the target cells. However, immunotoxins containing an anti-B1 antibody showed no cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4044586

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Design of liposome to improve encapsulation efficiency of gelonin and its effect on immunoreactivity and ribosome inactivating property.

Authors:  A Alam; S R Bhuri; A K Mavila; V Singh
Journal:  Mol Cell Biochem       Date:  1992-06-26       Impact factor: 3.396

2.  A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2.

Authors:  K Mujoo; R A Reisfeld; L Cheung; M G Rosenblum
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells.

Authors:  U C Wargalla; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates.

Authors:  N L Letvin; V S Goldmacher; J Ritz; J M Yetz; S F Schlossman; J M Lambert
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

5.  Requirements for the construction of antibody heterodimers for the direction of lysis of tumors by human T cells.

Authors:  C F Scott; W A Blättler; J M Lambert; R S Kalish; C Morimoto; S F Schlossman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

6.  Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide.

Authors:  D E Kerr; P D Senter; W V Burnett; D L Hirschberg; I Hellström; K E Hellström
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells.

Authors:  P L Tazzari; L Barbieri; M Gobbi; A Dinota; S Rizzi; A Bontadini; A Pession; S Tura; F Stirpe
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Characterization of the increased cytotoxicity of gelonin anti-T cell immunoconjugates compared with ricin A chain immunoconjugates.

Authors:  D M Fishwild; H M Wu; S F Carroll; S L Bernhard
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  Therapy of murine pulmonary aspergillosis with antibody-alliinase conjugates and alliin.

Authors:  Elena Appel; Alexandra Vallon-Eberhard; Aharon Rabinkov; Ori Brenner; Irina Shin; Keren Sasson; Yona Shadkchan; Nir Osherov; Steffen Jung; David Mirelman
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

10.  Effectiveness of an adriamycin immunoconjugate that recognizes the C-erbB-2 product on breast cancer cell lines.

Authors:  H Jinno; M Ueda; K Enomoto; T Ikeda; P Kyriakos; M Kitajima
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.